Small cell lung cancer (SCLC) is a metastatic malignancy characterised by high initial response rates to conventional chemotherapy and the consequent emergence of drug resistance (Minna et al., 1989) . New anti-tumour agents that have the potential to act systemically and by novel mechanisms able to circumvent drug resistance could make a significant contribution to the treatment of SCLC. We have recently begun to investigate the potential of immunotoxins made by linking ricin A chain to monoclonal antibodies (Mabs) recognising SCLC-associated antigens (Wawrzynczak et al., 1990 Derbyshire et al., 1992) . Ricin A chain immunotoxins have been administered to cancer patients systemically and selectively intoxicate target cells by inactivating ribosomes (Wawrzynczak, 1992; .
Two international workshops on SCLC antigens have defined eight clusters of Mabs which react with distinct cell surface antigens associated with SCLC (Souhami et al., 1987 . In a preliminary study using an indirect assay of immunotoxin cytotoxicity, we identified that cluster 2 Mabs from the Second International Workshop were generally effective in delivering ricin A chain to the cytosol . From these results, we predicted that an immunotoxin made by the direct chemical linkage of ricin A chain to a cluster 2 Mab should be selectively and potently toxic to SCLC cell lines. In this study, we have constructed a cluster 2 immunotoxin, MOC-31-ricin A chain, determined its cytotoxic properties using a panel of human tumour cell lines, and have examined the factors influencing the selectivity and accuracy of the indirect assay. isotype, SL2.21 of the IgG2a isotype, MOC-58 and MOC-181 of undetermined isotypes, and the rat Mab LCA2 of the IgG2a isotype .
Preparation of immunotoxins
The mouse Mab MOC-31, of the IgG1 isotype (de Leij et al., 1986) , recognises the SCLC-associated cluster 2 antigen (Beverley et al., 1988) . The mouse Mab W3/25, also of the IgGl isotype and recognising the rat homologue of the human CD4 antigen, was used as an irrelevant control Mab. The Mabs were linked to ricin A chain via a disulphide bond according to the procedure described by Cumber & Wawrzynczak (1992) . Briefly, the purified Mab was reacted with N-succinimidyl 3-(2-pyridyldithio)propionate to introduce an average of about two 2-pyridyldisulphide groups into the Mab. The derivatised Mab was allowed to react overnight with a 2.5-fold molar excess of freshly reduced ricin A chain and the mixture was applied to a column of Sephacryl S200(HR). Protein fractions of eluate were analysed by sodium dodecyl sulphate polyacrylamide gel electrophoresis and fractions corresponding to conjugate molecules consisting predominantly of one ricin A chain molecule linked to one Mab molecule were pooled to form the final preparation of immunotoxin.
Immunotoxin screening agents for use with mouse and rat Mabs were prepared by chemically linking ricin A chain to the Fab' fragments of sheep anti-mouse IgG (SAMIgG) and sheep anti-rat Ig (SARIg) respectively (Wawrzynczak et al., 1990; .
Cell lines
The panel of human SCLC cell lines comprised the classic GLC-8 line (Postmus et al., 1988) , the classic NCI-H69 line (Carney et al., 1985) provided by Dr L. Kelland at the Institute of Cancer Research, Sutton, UK and the variant SW2 line provided by Dr R. Stahel at the University Hospital, Zurich, Switzerland. The lung adenocarcinoma cell lines NCI-H23 and NCI-H125 (Carney et al., 1985) were provided by Dr V. Macauley at the Institute of Cancer Research, Sutton, UK. The human T-lymphoblastoid cell line CEM was obtained from the American Type Tissue Culture Collection.
Cell lines were maintained in a humidified atmosphere of 5% CO2 in air at 37°C. The lines were cultured in RPMI-1640 supplemented with 10% (v/v) heat inactivated foetal calf serum, 2mM L-glutamine, 100IUml-' penicillin, and 100 tg ml-' streptomycin. SCLC cells growing as aggregates in suspension and adenocarcinoma cell lines growing as monolayer cultures were disaggregated to predominantly single cells for use in experiments as described previously (Wawrzynczak et al., 1990) . The T-lymphoblastoid cell line grew as a suspension of single cells in tissue culture. Cell suspensions for cytotoxicity assays were prepared in medium containing leucine-free RPMI (assay medium).
Indirect immunofluorescence analysis of Mab binding to NCI-H69 cells NCI-H69 cells were adjusted to a density of 1 x 106 cells ml-' in assay medium and mixed with an equal volume of each of the cluster 2 Mab samples from the Second International Workshop. The cells were incubated on ice for 30 min and indirect immunofluorescence and flow cytometry was performed as described previously . The relative mean fluorescence intensity (MFI) of single live NCI-H69 cells was measured.
Cytotoxicity assays
The indirect assay of immunotoxin cytotoxicity was performed essentially as described previously . Briefly, cell suspensions at a density of The continuous cytotoxicity assays were performed essentially as described previously (Wawrzynczak et al., 1990 (Figure 2b) . In a further control experimen of MOC-31 and the screening agent was toxic to the T-lymphoblastoid cell line, CE ing of MOC-3 1 could not be dete immunofluorescence and flow cytometry result confirmed that the cytotoxic effec MOC-31 againt the NCI-H69 cell line in were dependent upon the presence of the the cell surface.
Factors influencing the predictive value of tht
The effect of the washing step upon the cy MOC-31 in the indirect assay was assessed. ,creening agent, or assay, cells were exposed to MOC-31, washed to remove icin A chain. This unbound Mab, and incubated with the screening agent at a icin A chain to the single concentration of 1 x 10'8 M. In the second arm of the for MOC-3 1 to assay, cells were exposed to MOC-3 1 and then incubated with the screening agent without the washing step. Coms seen with MOCparison of the results using the two protocols revealed that t, the combination the washing step made little difference to the cytotoxic effects he screening agent (Figure 3a) centrations. The IC50 of MOC-31-ricin A chain in this continuous assay was 10-fold lower than in the discontinuous assay shown in Figure 3b presumably reflecting a greater uptake of immunotoxin upon prolonged incubation. However, this ICm was still 30-fold higher than that determined by the indirect assay (Figure 3a) .
Unconjugated MOC-31 at a concentration of 1 x 1O-7M inhibited the selective cytotoxic action of MOC-31-ricin A chain whereas the isotype-matched control Mab W3/25 could not block the action of the immunotoxin (Figure 4b) indicating that the antigen binding sites of MOC-31 were responsible for binding the immunotoxin to the cell surface. A chain was also potently toxic to the NCI-H125 lung adenocarcinoma cell line, which expresses the cluster 2 antigen, with an IC50 of 6.5 x 10-"I M.
MOC-3 1-ricin A chain demonstrated no selective toxic effects against the NCI-H23 lung adrenocarcinoma cell line NCI-H69 GLC-8 MOC-31-ricin A chain 2.3 ± 1.6 x 10-10 2.8 ± 2.1 x 10-11
1.6 ± 1.1 x 10-rn W3/25-ricin A chain 3.5 ± 0.6 x 10-8 > 1.0 x 10-7 > 1.0 X 10-7 Ricin A chain 3.2 ± 0.2 x 10-8 2.6 ± 0.4 x 10-8 5.8 ± 2.3 x 10-8 Ricin 2.9 ± 1.7 x 10-13 7.9 ± 3.2 x 10- . This finding actually assisted in identifying some of the Mabs finally assigned to cluster 2 Although MOC-31-ricin A chain was not as potently toxic as predicted by the indirect assay, the immunotoxin was shown to be selectively toxic to all three SCLC cell lines examined upon continuous exposure for 48 h. In addition to the three SCLC cell lines, MOC-31-ricin A chain was toxic to the NCI-H 125 lung adrenocarcinoma cell line which expresses the target antigen. The cluster 2 antigen is an epithelial cell-surface glycoprotein with a molecular mass of about 35 kDa (Perez & Walker, 1989; Strnad et al., 1989; Durbin et al., 1990) . This antigen has a similar predicted amino acid sequence to other cloned antigens (Linnenbach et al., 1989; Simon et al., 1990) . These data unite the cluster 2 Mabs identified in the Workshop with other Mabs that appear to recognise the same or closely related antigens.
Two cluster 2-related Mabs, namely 17-lA and LDI, have previously been chemically linked to ricin A chain (Gilliland et al., 1980; Blakey et al., 1993 (Shen et al., 1984; Elias et al., 1990) .
Whether this normal tissue reactivity would prove a serious limitation of immunotoxin therapy remains to be determined.
In conclusion, the cytotoxic effects measured by the indirect immunotoxin assay are sensitive to the nature of the target antigen, to the amount of Mab that binds to the target cell surface and to the relative molar amounts of Mab and screening agent. The results of indirect screens with Mabs which recognise different antigens cannot be relied upon to give a accurate guide to the relative potency of the corresponding directly-linked A chain ITs unless the Mab concentrations are defined and the concentration of the screening agent is precisely matched to that of the Mab.
